Karol Timmons
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Karol Timmons.
Annals of Allergy Asthma & Immunology | 2008
Jennifer LeBovidge; Karol Timmons; Christine Rich; Addie Rosenstock; Kirsten Fowler; Heather Strauch; Leslie A. Kalish; Lynda C. Schneider
BACKGROUND Children with food allergy and their parents may experience substantial stress related to the risk of serious reactions and the demands of allergy management. OBJECTIVE To evaluate a group intervention for children with food allergy and their parents designed to increase parent-perceived competence in coping with food allergy and to decrease the parent-perceived burden associated with food allergy. METHODS Sixty-one children aged 5 to 7 years with food allergy and their parents attended 1 of 4 half-day workshops, with parent and child groups run concurrently. Parents completed self-report measures of perceived competence in coping with food allergy at 3 time points: preworkshop (within 8 weeks of the intervention), postworkshop (immediately after the intervention), and follow-up (4-8 weeks after the intervention). Parents completed a measure of burden associated with food allergy at preworkshop and follow-up. Parents and children also completed evaluations of the study intervention. RESULTS Parent-perceived competence in coping with food allergy increased significantly from preworkshop to postworkshop and follow-up, and parent-perceived burden associated with food allergy decreased from preworkshop to follow-up. Parent and child evaluations of the workshop were favorable. CONCLUSIONS These findings provide preliminary support for the effectiveness and feasibility of a group intervention for children with food allergy and their parents and suggest the importance of controlled evaluations of group interventions in this population in the future.
The Journal of Allergy and Clinical Immunology: In Practice | 2014
Peter A. Lio; Margaret S. Lee; Jennifer LeBovidge; Karol Timmons; Lynda C. Schneider
Atopic dermatitis is a challenging condition for clinicians and patients. Recent advances were documented in the Atopic Dermatitis Practice Parameter 2012, and we want to provide clinicians with key points from the Atopic Dermatitis Practice Parameter 2012. In this article, we highlight the evidence-based therapy of atopic dermatitis as well as provide practical tips for clinicians and families. An updated review of immunopathology provides a firm basis for patient education and therapy. We also review clinical diagnosis and ways to improve quality of life for patients with atopic dermatitis.
The Journal of Allergy and Clinical Immunology | 2016
Jennifer LeBovidge; Wendy Elverson; Karol Timmons; Elena B. Hawryluk; Corinna Rea; Margaret S. Lee; Lynda C. Schneider
Atopic dermatitis (AD) is the most common pediatric skin disease. AD has a significant effect on patient and family quality of life caused by intense pruritus, sleep disruption, dietary and nutritional concerns, and psychological stress associated with the disease and its management. Multidisciplinary approaches to AD care have been developed in appreciation of the complex interplay among biological, psychological, behavioral, and dietary factors that affect disease control and the wide range of knowledge, skills, and support that patients and families require to effectively manage and cope with this condition. Common components of multidisciplinary treatment approaches include medical evaluation and management by an AD specialist, education and nursing care, psychological and behavioral support, and nutritional assessment and guidance. Models of care include both clinical programs and structured educational groups provided as adjuncts to standard clinical care. Available evidence suggests beneficial effects of multidisciplinary interventions in improving disease severity and quality of life, particularly for patients with moderate-to-severe disease. Additional research is needed to identify the best candidates for the various multidisciplinary approaches and evaluate the cost-effectiveness of these programs.
Allergy and Asthma Proceedings | 2011
Janet Chou; Jennifer LeBovidge; Karol Timmons; Wendy Elverson; Jaclyn Morrill; Lynda C. Schneider
Atopic dermatitis (AD) is one of the most common pediatric skin disorders. Because treatment involves allergen avoidance, dietary changes, and behavior modification, multidisciplinary treatment models have been used to complement conventional medication therapy. However, predictors of clinical response in these multidisciplinary models have not been studied. This study examined factors associated with a reduction in AD severity in a multidisciplinary outpatient pediatric AD treatment program providing medical, nutritional, and behavioral support. Data were collected from 170 patients between 2001 and 2006. The Eczema Area and Severity Index (EASI) score was determined at the time of each visit. Using a logistic regression model, we investigated the association of baseline demographic and clinical characteristics with clinical outcome. We also analyzed the association between improvement in the EASI score and behavioral changes. One hundred thirty-eight patients had significantly improved EASI scores, and 32 patients were nonresponders. Responders had a median improvement of 79% in their EASI score, whereas nonresponders had a 53% worsening of their EASI score (p < 0.0001) and a significantly worse absolute EASI score (p < 0.001). Predictors of clinical success included baseline EASI score, baseline age, and improved parental adherence to treatment recommendations. Improvement in the EASI score significantly correlated with quality-of-life measures: decreased itching and scratching, difficulty sleeping, and parental concerns about side effects. A multidisciplinary model of AD treatment has the best clinical outcomes in younger patients with severe AD. Ensuring parental compliance with treatment recommendations is important for clinical response.
The Journal of Allergy and Clinical Immunology: In Practice | 2016
Tander Simberloff; Ron Parambi; Lisa M. Bartnikas; Ana Dioun Broyles; Victoria Hamel; Karol Timmons; D. Marlowe Miller; Dionne A. Graham; Lynda C. Schneider; Andrew J. MacGinnitie
BACKGROUND Oral food challenges (OFCs) are routinely used to confirm ongoing food allergy. Serum-specific IgE (sIgE) and skin prick testing (SPT) are imperfect predictors of which patients will pass OFCs. OBJECTIVE The objective of this study was to describe the design and implementation of a Standardized Clinical Assessment and Management Plan (SCAMP) to study and iteratively improve sIgE and SPT thresholds to determine when and where to conduct OFCs for patients. METHODS Allergists consulted recommended sIgE and SPT thresholds when ordering challenges although diversions were permitted. Criteria were iteratively improved after periodic analyses of challenge outcome and diversions. RESULTS Over 3 years, allergists ordered 2368 food challenges for 1580 patients with histories of IgE-mediated reactions to food: 1386 in an outpatient clinic and 945 in a higher resource infusion center. Reactions to challenge were observed in 13% of clinic and 23% of infusion center challenges. Six patients challenged in clinic required treatment with epinephrine compared with 22 in the infusion center. The need for epinephrine was more common in patients with asthma-5% of asthmatic patients required epinephrine compared with 1% of nonasthmatic patients (P < .01). Recommended sIgE and SPT thresholds were incrementally changed and, using the control chart methodology, a significant decrease was noted in the proportion of challenges ordered in the higher resource location. CONCLUSIONS By setting and continually refining sIgE and SPT recommendations using the SCAMP method, allergists can better determine the risk of severe reaction and triage patients to the appropriate setting for an OFC.
Journal of Clinical Medicine | 2015
Sara C. Spielman; Jennifer LeBovidge; Karol Timmons; Lynda C. Schneider
Multidisciplinary interventions have been developed for patients with atopic dermatitis (AD) and their families, with the aim of improving outcomes such as disease control, adherence, and quality of life. We reviewed the content of different multidisciplinary approaches to intervention for AD and evidence for their impact on key outcome measures. We also provided data from our multidisciplinary outpatient program for pediatric AD. Studies included in the review suggest benefits of multidisciplinary interventions as models of treatment or adjuncts to standard medical care, with a positive impact on outcomes including disease severity and itching/scratching. There were limitations to existing studies, including heterogeneous methods used to assess quality of life outcomes across studies and lack of controlled studies assessing the outcome of clinical care programs. Further research will be useful in assessing the impact of multidisciplinary interventions on important outcomes such as treatment adherence and sleep, identifying the elements of multidisciplinary interventions that are most critical for improved outcomes, and identifying the best candidates for multidisciplinary intervention approaches.
Pediatric Allergy and Immunology | 2018
Andrew J. MacGinnitie; Radhika Kamalia; Luis Alvernaz; Karol Timmons; Victoria Hamel; Alexander Lafreniere; Brian Minsk; Craig D. Platt; Pui Lee; Elizabeth Burke-Roberts; Meredith A. Dilley
Food challenges are critical to determine if an individual has food allergy when history and testing are inconclusive or the allergy may have been outgrown.(1) Passing a challenge may have nutritional, psychological and financial benefits.(1-3) We and others have shown that challenges can be safely carried out in a clinic setting.(4-9) This article is protected by copyright. All rights reserved.
Journal of Pediatric Psychology | 2006
Jennifer LeBovidge; Susan Douglas Kelley; Allison Lauretti; Evan P. Bailey; Karol Timmons; Allison K. Timmons; Melissa Van Horn; Lauren Raezer Blakely; Lynda C. Schneider
Allergy and Asthma Proceedings | 2011
K Issa-El-Khoury; Jl Bayuk; Sarita U. Patil; Morris Ling; Aidan A. Long; Paul E. Hesterberg; Aleena Banerji; Jillian F. Rork; William J. Sheehan; Jonathan M. Gaffin; Karol Timmons; Robert Sidbury; Lynda C. Schneider; Wanda Phipatanakul; Cf Cortot; Sachin N. Baxi; Anahita F. Dioun
The Journal of Allergy and Clinical Immunology | 2007
Jennifer LeBovidge; Karol Timmons; C. Rich; A. Rosenstock; Kirsten Fowler; Lynda C. Schneider